Biotech · Private company
Definium Therapeutics US, Inc.
Track this companyFree. Adds Definium Therapeutics US, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials75 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- DT120Phase 3 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- DT120Phase 3 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- DT402 (R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA))Phase 2 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- MM120Phase 2 · Anxiety GeneralizedClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)PHASE3 · RECRUITING · started May 10, 2026ClinicalTrials.gov NCT07592689 · fetched Nov 12, 2026
- A Phase 2A Trial of DT402 for Autism Spectrum DisorderPHASE2 · RECRUITING · started Dec 3, 2025ClinicalTrials.gov NCT07303907 · fetched Nov 12, 2026
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 14, 2025ClinicalTrials.gov NCT06941844 · fetched Nov 12, 2026
- A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 29, 2025ClinicalTrials.gov NCT06809595 · fetched Nov 12, 2026
- A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 11, 2024ClinicalTrials.gov NCT06741228 · fetched Nov 12, 2026
- My Experiences: Leveraging Digital Technologies to Better Understand Mental HealthCOMPLETED · started Jun 26, 2023ClinicalTrials.gov NCT05753605 · fetched Nov 12, 2026
- A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsPHASE2 · COMPLETED · started Aug 24, 2022ClinicalTrials.gov NCT05407064 · fetched Nov 12, 2026